๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || New Biologic Drugs: Anti-Interleukin Therapy

โœ Scribed by Miserocchi, E.; Modorati, G.; Foster, C.S.


Book ID
115478569
Publisher
S. KARGER AG
Year
2012
Tongue
English
Weight
355 KB
Edition
1
Category
Article
ISBN
3805599870
ISSN
0250-3751

No coin nor oath required. For personal study only.

โœฆ Synopsis


Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.


๐Ÿ“œ SIMILAR VOLUMES


[Developments in Ophthalmology] New Trea
โœ Miserocchi, E.; Modorati, G.; Foster, C.S. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› S. KARGER AG ๐ŸŒ English โš– 153 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea
โœ Miserocchi, E.; Modorati, G.; Foster, C.S. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› S. KARGER AG ๐ŸŒ English โš– 313 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea
โœ Miserocchi, E.; Modorati, G.; Foster, C.S. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› S. KARGER AG ๐ŸŒ English โš– 299 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea
โœ Miserocchi, E.; Modorati, G.; Foster, C.S. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› S. KARGER AG ๐ŸŒ English โš– 90 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao